, a bio/informatics shared resource is still "open for business" - Visit the CDS website

  1. iNKT-cell responses to glycolipids. Parekh VV, Wilson MT, Van Kaer L (2005) Crit Rev Immunol 25(3): 183-213
    › Primary publication · 16048435 (PubMed)
  2. Hepatocytes express abundant surface class I MHC and efficiently use transporter associated with antigen processing, tapasin, and low molecular weight polypeptide proteasome subunit components of antigen processing and presentation pathway. Chen M, Tabaczewski P, Truscott SM, Van Kaer L, Stroynowski I (2005) J Immunol 175(2): 1047-55
    › Primary publication · 16002705 (PubMed)
  3. Glycolipid antigen induces long-term natural killer T cell anergy in mice. Parekh VV, Wilson MT, Olivares-Villagómez D, Singh AK, Wu L, Wang CR, Joyce S, Van Kaer L (2005) J Clin Invest 115(9): 2572-83
    › Primary publication · 16138194 (PubMed) · PMC1193878 (PubMed Central)
  4. Distinct roles of dendritic cells and B cells in Va14Ja18 natural T cell activation in vivo. Bezbradica JS, Stanic AK, Matsuki N, Bour-Jordan H, Bluestone JA, Thomas JW, Unutmaz D, Van Kaer L, Joyce S (2005) J Immunol 174(8): 4696-705
    › Primary publication · 15814694 (PubMed)
  5. Direct effects of T-bet and MHC class I expression, but not STAT1, on peripheral NK cell maturation. Robbins SH, Tessmer MS, Van Kaer L, Brossay L (2005) Eur J Immunol 35(3): 757-65
    › Primary publication · 15719366 (PubMed)
  6. Cooperation of invariant NKT cells and CD4+CD25+ T regulatory cells in the prevention of autoimmune myasthenia. Liu R, La Cava A, Bai XF, Jee Y, Price M, Campagnolo DI, Christadoss P, Vollmer TL, Van Kaer L, Shi FD (2005) J Immunol 175(12): 7898-904
    › Primary publication · 16339525 (PubMed)
  7. Commitment toward the natural T (iNKT) cell lineage occurs at the CD4+8+ stage of thymic ontogeny. Bezbradica JS, Hill T, Stanic AK, Van Kaer L, Joyce S (2005) Proc Natl Acad Sci U S A 102(14): 5114-9
    › Primary publication · 15792999 (PubMed) · PMC555981 (PubMed Central)
  8. alpha-Galactosylceramide therapy for autoimmune diseases: prospects and obstacles. Van Kaer L (2005) Nat Rev Immunol 5(1): 31-42
    › Primary publication · 15630427 (PubMed)
  9. The Ig-like domain of tapasin influences intermolecular interactions. Turnquist HR, Petersen JL, Vargas SE, McIlhaney MM, Bedows E, Mayer WE, Grandea AG, Van Kaer L, Solheim JC (2004) J Immunol 172(5): 2976-84
    › Primary publication · 14978101 (PubMed)
  10. Regulation of immune responses by CD1d-restricted natural killer T cells. Van Kaer L (2004) Immunol Res 30(2): 139-53
    › Primary publication · 15477656 (PubMed)